Trade Mark Journal No.2026/044 30 October 2026

UK00004459846 14 October 2026 (5)

TRUHEPLI

International priority date claimed: 9 October 2026 (United States of America) (50153651)

Class 5: Pharmaceutical preparations for use in the treatment and prevention of hepatitis D infections, hepatitis B infections, fulminant hepatitis, liver cirrhosis, hepatocellular carcinoma, and liver failure.

Mirum Pharmaceuticals, Inc.

Representative: Mohun Aldridge Sykes Limited